Anti-alpha4beta7 MAb regimen leads to SIV suppression long after treatment in monkeys Nov. 2, 2016 No Comments
Gilead opens phase II/III study of fixed-dose combination in young patients with HIV-1 infection Oct. 7, 2016 No Comments
Viiv Healthcare starts phase III trial for two-drug regimen of dolutegravir/lamivudine Aug. 18, 2016 No Comments
RSS